opiate;
tolerance;
withdrawal;
DSP-3 (N-(2-chloroethyl)-N-ethyl-2-bromobenzyl;
Locus ceruleus;
(mouse);
D O I:
10.1016/0014-2999(96)00318-4
中图分类号:
R9 [药学];
学科分类号:
1007 [药学];
摘要:
The ability of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4), a potent and selective noradrenergic neurotoxic compound, to modify morphine tolerance and dependence was investigated in mice. DSP-4 pretreatment, either 50 or 100 mg/kg i.p., had no effect on the development of tolerance to the analgesic effect of morphine evaluated by the tail-flick test. On the contrary, the higher dose of DSP-4 prevented repetitive vertical jumping, a major naloxone-precipitated withdrawal symptom in mice. These results demonstrate that coerulean neuronal projections are not necessary for the development of tolerance but are clearly involved in the expression of withdrawal-induced jumping in mice.